These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Genetic factors in neurodegenerative diseases. Tsuang DW; Bird TD Am J Med Genet B Neuropsychiatr Genet; 2017 Jan; 174(1):3-4. PubMed ID: 27770499 [No Abstract] [Full Text] [Related]
46. A meeting of minds: overcoming roadblocks in the development of therapies for neurodegenerative disorders. Muqit MM; Alessi DR EMBO Mol Med; 2009 Jun; 1(3):139-41. PubMed ID: 20049713 [No Abstract] [Full Text] [Related]
47. Unravelling proteinopathies: an interview with David Rubinsztein. Rubinsztein D Dis Model Mech; 2015 Jul; 8(7):643-6. PubMed ID: 26092526 [TBL] [Abstract][Full Text] [Related]
49. [A plan for neurodegenerative diseases]. Debertrand N Soins Gerontol; 2015; (111):5. PubMed ID: 25751916 [No Abstract] [Full Text] [Related]
50. Goals in tension: motivated by genetic disease yet rooted in basic science. Wang ET Nat Rev Mol Cell Biol; 2021 Sep; 22(9):581-582. PubMed ID: 34183812 [No Abstract] [Full Text] [Related]
51. Food, Dietary Supplements and Nutraceuticals in Aging and Neurodegenerative Diseases. De Marchi F; Tondo G CNS Neurol Disord Drug Targets; 2024; 23(5):543-544. PubMed ID: 38666506 [No Abstract] [Full Text] [Related]
52. Highlights of the issue 11, 2018. Neurol Sci; 2018 Nov; 39(11):1823-1825. PubMed ID: 30324252 [No Abstract] [Full Text] [Related]
53. Ribosome-associated protein quality control: Implications for neurodegenerative diseases and therapeutic potential. Gao Y; Zhu Y; Sun Q; Chen D Sci Bull (Beijing); 2024 May; 69(9):1165-1169. PubMed ID: 38278708 [No Abstract] [Full Text] [Related]
54. International Workshop on Conformational Diseases, Dead Sea, Israel, November 8-12, 1998 (sponsored by the Center for the Study of Emerging Diseases (CSED)). Solomon B; Taraboulos A; Katchalski-Katzir E Amyloid; 1999 Sep; 6(3):225-8. PubMed ID: 10524289 [No Abstract] [Full Text] [Related]
55. Editorial: New Avenues and Therapeutic Strategies for the Treatment of Neurodegenerative Diseases. Esteves AR Curr Pharm Des; 2017; 23(5):667-668. PubMed ID: 28590229 [No Abstract] [Full Text] [Related]
56. Thematic Selection: Strategies of Current Drugs and Alternative Treatments for Neurodegenerative Diseases. Wang XP; Chen HZ Curr Neuropharmacol; 2016; 14(4):301. PubMed ID: 27071948 [No Abstract] [Full Text] [Related]
57. Advances in the treatment of neurodegenerative diseases and epilepsy. Camins A Curr Pharm Des; 2013; 19(38):6699-700. PubMed ID: 23530519 [No Abstract] [Full Text] [Related]